# Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

> **NCT05510323** · PHASE3 · RECRUITING · sponsor: **Air Force Military Medical University, China** · enrollment: 208 (estimated)

## Conditions studied

- Glomerulonephritis, IGA

## Interventions

- **DRUG:** Prednisolone
- **DRUG:** Prednisolone plus Cyclophosphamide

## Key facts

- **NCT ID:** NCT05510323
- **Lead sponsor:** Air Force Military Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2025-08
- **Final completion:** 2028-08
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05510323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05510323, "Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05510323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*